| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
11,517 |
10,522 |
$4.15M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
21,455 |
20,480 |
$2.42M |
| 87428 |
|
11,038 |
10,383 |
$746K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,122 |
1,946 |
$712K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
7,460 |
7,245 |
$601K |
| 80053 |
Comprehensive metabolic panel |
36,637 |
29,971 |
$593K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,745 |
3,416 |
$542K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
6,811 |
1,523 |
$437K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
16,011 |
12,886 |
$411K |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,268 |
3,855 |
$353K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
42,368 |
33,576 |
$312K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,291 |
1,186 |
$309K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,173 |
1,288 |
$305K |
| 59025 |
Fetal non-stress test |
1,559 |
997 |
$208K |
| 71045 |
Radiologic examination, chest; single view |
13,652 |
12,075 |
$207K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
762 |
677 |
$157K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
9,193 |
7,983 |
$145K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
7,931 |
3,833 |
$120K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
885 |
785 |
$111K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,692 |
1,540 |
$110K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
794 |
434 |
$108K |
| 71046 |
Radiologic examination, chest; 2 views |
5,682 |
5,177 |
$93K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
821 |
744 |
$90K |
| 81001 |
|
24,003 |
21,052 |
$82K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
2,554 |
1,209 |
$80K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,505 |
1,385 |
$80K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,281 |
4,854 |
$77K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,334 |
1,233 |
$75K |
| 84484 |
|
10,011 |
6,728 |
$74K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
95 |
83 |
$70K |
| 83880 |
|
3,547 |
3,126 |
$70K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
626 |
583 |
$66K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
6,449 |
5,076 |
$63K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
948 |
899 |
$61K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
499 |
452 |
$60K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
716 |
373 |
$54K |
| 86901 |
|
2,419 |
2,035 |
$50K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,225 |
2,927 |
$47K |
| 87486 |
|
1,290 |
1,186 |
$46K |
| 87581 |
|
1,290 |
1,186 |
$46K |
| 36415 |
Collection of venous blood by venipuncture |
12,955 |
10,216 |
$44K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
870 |
676 |
$42K |
| 83605 |
|
4,772 |
3,926 |
$39K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
641 |
558 |
$39K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
11,319 |
7,546 |
$39K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,052 |
893 |
$39K |
| 87420 |
|
2,890 |
2,728 |
$38K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
5,453 |
4,951 |
$38K |
| 83690 |
|
5,591 |
4,857 |
$34K |
| 81025 |
|
4,528 |
3,997 |
$33K |
| 20610 |
|
368 |
300 |
$32K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
2,815 |
1,320 |
$31K |
| 87081 |
|
3,912 |
3,593 |
$31K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
3,031 |
2,380 |
$29K |
| 87040 |
|
3,394 |
1,850 |
$28K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,366 |
436 |
$27K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
781 |
743 |
$26K |
| 80305 |
|
2,168 |
1,960 |
$26K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,336 |
1,191 |
$24K |
| 82565 |
|
1,947 |
1,660 |
$23K |
| 84702 |
|
2,353 |
1,971 |
$22K |
| 83735 |
|
4,997 |
3,768 |
$22K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,393 |
3,688 |
$20K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
64 |
53 |
$18K |
| 82962 |
|
7,693 |
3,884 |
$18K |
| 86850 |
|
1,312 |
1,082 |
$18K |
| 97161 |
|
345 |
314 |
$18K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,620 |
3,895 |
$16K |
| 80050 |
General health panel |
359 |
345 |
$15K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
4,020 |
3,539 |
$15K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,000 |
874 |
$15K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,010 |
2,359 |
$14K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,971 |
1,565 |
$14K |
| 73562 |
|
568 |
492 |
$14K |
| 97162 |
|
322 |
285 |
$13K |
| 85610 |
|
5,572 |
4,817 |
$13K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
351 |
342 |
$12K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,764 |
2,564 |
$12K |
| 73030 |
|
738 |
652 |
$12K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,452 |
2,184 |
$11K |
| 82077 |
|
929 |
748 |
$11K |
| 72141 |
|
49 |
48 |
$11K |
| 87186 |
|
2,370 |
1,813 |
$10K |
| 76801 |
|
294 |
250 |
$10K |
| 73110 |
|
601 |
494 |
$9K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
51 |
49 |
$9K |
| 85730 |
|
2,504 |
2,219 |
$8K |
| 86900 |
|
2,422 |
2,035 |
$8K |
| 73610 |
|
604 |
505 |
$8K |
| 73630 |
|
408 |
359 |
$8K |
| 85027 |
|
1,839 |
1,603 |
$8K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,763 |
2,615 |
$7K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
413 |
353 |
$7K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
156 |
101 |
$7K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
255 |
236 |
$7K |
| 72100 |
|
356 |
337 |
$7K |
| 84703 |
|
925 |
795 |
$7K |
| 80320 |
|
462 |
408 |
$7K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
31 |
26 |
$7K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
30 |
27 |
$7K |
| J3490 |
Unclassified drugs |
2,079 |
781 |
$7K |
| 87077 |
|
1,041 |
814 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,238 |
1,154 |
$6K |
| 87210 |
|
1,114 |
931 |
$6K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
32 |
30 |
$6K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
58 |
56 |
$5K |
| G0378 |
Hospital observation service, per hour |
1,555 |
700 |
$5K |
| 93975 |
|
84 |
75 |
$5K |
| 73502 |
|
290 |
250 |
$4K |
| 93971 |
|
128 |
117 |
$4K |
| 85379 |
|
533 |
495 |
$4K |
| 76818 |
|
483 |
199 |
$4K |
| 86328 |
|
326 |
281 |
$4K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
268 |
132 |
$4K |
| 73130 |
|
225 |
190 |
$4K |
| 74018 |
|
266 |
226 |
$3K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,319 |
1,929 |
$3K |
| 82728 |
|
338 |
306 |
$3K |
| 80061 |
Lipid panel |
483 |
454 |
$3K |
| 93017 |
|
80 |
77 |
$3K |
| 71020 |
|
330 |
309 |
$3K |
| 80143 |
|
208 |
152 |
$3K |
| 86140 |
|
612 |
536 |
$3K |
| 95811 |
|
16 |
14 |
$3K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,480 |
2,396 |
$2K |
| 87088 |
|
324 |
288 |
$2K |
| 80179 |
|
188 |
139 |
$2K |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
1,458 |
1,247 |
$2K |
| 76830 |
Ultrasound, transvaginal |
44 |
41 |
$2K |
| 82553 |
|
248 |
216 |
$2K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
216 |
146 |
$2K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
53 |
51 |
$2K |
| 73560 |
|
113 |
104 |
$2K |
| 80329 |
|
159 |
81 |
$2K |
| 94760 |
|
249 |
157 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
46 |
42 |
$1K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
46 |
42 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,170 |
1,342 |
$1K |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
91 |
79 |
$1K |
| 84466 |
|
174 |
161 |
$1K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,026 |
2,333 |
$1K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
681 |
204 |
$1K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
34 |
34 |
$1K |
| 83615 |
|
211 |
183 |
$1K |
| 82607 |
|
214 |
205 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
80 |
79 |
$1K |
| 81003 |
|
622 |
575 |
$1K |
| 76376 |
|
79 |
66 |
$954.30 |
| 76642 |
|
33 |
26 |
$948.46 |
| 71010 |
|
208 |
190 |
$909.00 |
| 71271 |
|
12 |
12 |
$755.12 |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
701 |
650 |
$743.16 |
| 73565 |
|
55 |
54 |
$725.91 |
| 83540 |
|
181 |
168 |
$695.97 |
| 87070 |
|
97 |
87 |
$669.38 |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,107 |
880 |
$627.89 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
248 |
195 |
$593.83 |
| 87807 |
|
81 |
68 |
$585.45 |
| 82947 |
|
92 |
89 |
$582.51 |
| A6453 |
Self-adherent bandage, elastic, non-knitted/non-woven, width less than three inches, per yard |
283 |
248 |
$566.20 |
| J2704 |
Injection, propofol, 10 mg |
1,730 |
1,397 |
$555.51 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,743 |
1,335 |
$536.53 |
| 84132 |
|
245 |
222 |
$503.54 |
| 97116 |
|
96 |
38 |
$445.36 |
| 85045 |
|
176 |
146 |
$435.05 |
| 71250 |
|
13 |
13 |
$430.00 |
| A9270 |
Non-covered item or service |
5,359 |
3,305 |
$417.74 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
379 |
319 |
$381.28 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
90 |
71 |
$371.20 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,156 |
620 |
$359.29 |
| 85652 |
|
179 |
159 |
$347.29 |
| 97166 |
|
15 |
12 |
$343.73 |
| 85014 |
|
320 |
287 |
$343.27 |
| 86920 |
|
19 |
12 |
$340.00 |
| 84100 |
|
98 |
70 |
$306.93 |
| 76770 |
|
14 |
12 |
$284.27 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
270 |
142 |
$270.43 |
| J1815 |
Injection, insulin, per 5 units |
134 |
76 |
$245.48 |
| 87205 |
|
83 |
74 |
$233.45 |
| 93356 |
|
98 |
85 |
$213.09 |
| 82805 |
|
19 |
13 |
$202.60 |
| 85007 |
|
68 |
61 |
$197.30 |
| 84295 |
|
82 |
79 |
$188.70 |
| 97016 |
|
35 |
12 |
$168.61 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
41 |
41 |
$162.87 |
| 73090 |
|
13 |
12 |
$152.00 |
| 94729 |
|
12 |
12 |
$144.60 |
| 82378 |
|
12 |
12 |
$135.45 |
| 94726 |
|
12 |
12 |
$132.66 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
46 |
45 |
$115.77 |
| 93296 |
|
14 |
12 |
$112.82 |
| 82150 |
|
20 |
17 |
$111.12 |
| 82746 |
|
13 |
12 |
$110.67 |
| 80076 |
|
14 |
13 |
$101.88 |
| 84439 |
|
12 |
12 |
$77.28 |
| 83037 |
|
40 |
39 |
$62.85 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
355 |
315 |
$59.66 |
| A6402 |
Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
70 |
66 |
$55.62 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
30 |
29 |
$49.59 |
| A6257 |
Transparent film, sterile, 16 sq. in. or less, each dressing |
48 |
45 |
$48.89 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
147 |
121 |
$47.65 |
| A6258 |
Transparent film, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing |
12 |
12 |
$43.81 |
| 96376 |
|
431 |
258 |
$40.87 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
38 |
30 |
$40.32 |
| J2785 |
Injection, regadenoson, 0.1 mg |
32 |
30 |
$37.07 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
149 |
112 |
$36.37 |
| J1644 |
Injection, heparin sodium, per 1000 units |
189 |
101 |
$35.03 |
| J2060 |
Injection, lorazepam, 2 mg |
64 |
44 |
$32.48 |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
17 |
13 |
$24.48 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
17 |
13 |
$15.33 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
15 |
12 |
$15.28 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
45 |
37 |
$5.34 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
223 |
189 |
$3.71 |
| G1010 |
Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program |
216 |
197 |
$0.26 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
283 |
271 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
229 |
177 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
30 |
24 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
13 |
13 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
36 |
30 |
$0.00 |
| 99152 |
|
13 |
12 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
13 |
13 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
12 |
12 |
$0.00 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
103 |
64 |
$0.00 |
| 90662 |
|
15 |
15 |
$0.00 |
| Q9969 |
Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose |
63 |
62 |
$0.00 |
| C1769 |
Guide wire |
111 |
105 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
39 |
38 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
19 |
18 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
15 |
13 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
68 |
63 |
$0.00 |
| 86769 |
|
39 |
20 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
50 |
50 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
17 |
16 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
22 |
14 |
$0.00 |
| A6450 |
Light compression bandage, elastic, knitted/woven, width greater than or equal to five inches, per yard |
14 |
12 |
$0.00 |
| 97014 |
|
47 |
13 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
15 |
12 |
$0.00 |